Related Experiment Videos
[Eosinophils and antitumour response]
R Costello1, T O'Callaghan, G Sébahoun
1Département d'hématologie (Pr Gérard Sébahoun), hôpital Nord, chemin des Bourrelly, 13915 Marseille cedex 20, France. Regis.Costello@ap-hm.fr
La Revue De Medecine Interne
|May 24, 2005
Summary
Eosinophils may fight tumors by directly contacting cancer cells. Future immunotherapies could enhance this anti-tumor effect by attracting and activating eosinophils within the tumor microenvironment.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Context:
- Tumor control involves immune responses, including cytotoxic T-lymphocytes and natural killer (NK) cells.
- Eosinophils, typically involved in allergies and parasitic infections, are increasingly associated with various cancers.
- Tumor-associated tissue eosinophilia (TATE) is often a favorable prognostic indicator, except in Hodgkin's disease.
Purpose:
- To explore the potential role of eosinophils in anti-tumor immune responses.
- To investigate the mechanisms by which eosinophils might contribute to cancer control.
Summary:
- Eosinophils' anti-tumor effects depend on their close proximity to tumor cells.
- Tumor-associated tissue eosinophilia (TATE) is a significant prognostic factor in many cancers.
- In Hodgkin's disease, eosinophils may promote tumor cell survival through specific signaling pathways.
Impact:
- Future immunotherapies could leverage eosinophils for cancer treatment.
- Strategies may involve direct cytokine injection or expression vectors to activate eosinophils within tumors.
- Targeting eosinophil-mediated anti-tumor immunity offers a novel therapeutic avenue.